← Research hub  ·  securities

MKL · Markel Group $1,786.51 +1.27 (+0.07%) 2026-SEP-18 12:47 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA13 mentions
2026-SEP-17 · Pieter Slegers · Compounding Quality (Substack, paid post) · Positiveinsight · read ↗ · source page ↗$1,800.00

In short: BUY — seventh on the Reverse-DCF list (−5.5% required vs 12.0%, +17.5pp). ER 11.41%; fwd PE 18.7 vs 17.6 (6.2% over). YTD −16.5%.

SOD $1,800.00
2026-AUG-23 · Pieter Slegers · Compounding Quality (Substack, paid post) · Positiveinsight · read ↗ · source page ↗$1,792.71

In short: BUY, on the reverse DCF alone: 0.7% growth required against 12.0% expected (+11.3pp), eighth-best in the universe. The multiple test disagrees — fwd PE 18.7 against a 17.6 average, 6.2% over — and the expected return is 11.41%. The "mini-Berkshire" of the coffee-can list; YTD −14.8%.

SOD $1,792.71 (open 2026-AUG-21)
2026-AUG-04 · Pieter Slegers · Compounding Quality (Substack, free post) · Neutralmention · read ↗ · source page ↗$1,879.09

In short: Named only as a board seat: Lawrence Cunningham "serves in the board of directors of Markel and Constellation Software." A standing coffee-can name elsewhere in this archive; no new view is offered here.

SOD $1,879.09
2026-JUL-09 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,967.32

In short: BUY. FV $2,331.2 vs $1,981.5 = 15.0% under; fwd PE 18.7 against a 17.6 average = 6.2% over; RDCF 4.0% vs 12.0% expected, an 8.0pp margin. YTD −7.0%.

SOD $1,967.32
2026-JUN-18 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,871.91

In short: BUY. FV $2,139.6 vs $1,818.7 = 15.0% under; ER 11.4%; fwd PE 18.7 against a 17.6 average = 6.2% over — like Fairfax, an insurance compounder whose multiple has not de-rated; RDCF 5.7% vs 12.0% expected, a 6.3pp margin.

SOD $1,871.91
2026-MAY-12 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,837.96

In short: The one company given a rationale — "a mini Berkshire", and the only individual stock Housel is said to own beyond his index funds (he sits on the board). "Markel makes money by selling specialty insurance to businesses and individuals. Just like Berkshire, the premiums they get from the insurance are invested in high quality private and public businesses." Three reasons listed: "Tom Gayner is an excellent CEO"; "incredible track record of creating shareholder value: 10.3% return since IPO in 1986"; and "low valuation levels."

In plain English

Markel sells specialist insurance — the unusual, hard-to-price risks that ordinary insurers avoid. The interesting part is what it does with the money. Customers pay their premiums up front and claims are paid out much later, so the company sits on a large pool of other people's cash in the meantime. That pool is called float, and Markel invests it in shares and whole private businesses.

It is the same machine Berkshire Hathaway is built on, which is why it is described here as "a mini Berkshire". If the insurance itself merely breaks even, the investment returns on the float are effectively free.

Three reasons are given for owning it: Tom Gayner, who runs the investment side, is rated an excellent chief executive; the shares have returned about 10.3% a year since listing in 1986, a forty-year record long enough that luck cannot explain it; and the price today is described as low.

It also happens to be the one individual company Morgan Housel — otherwise an index-fund advocate — owns and sits on the board of, which is the reason it appears at the end of an article about him.

SOD $1,837.96
2026-MAY-07 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,781.10

In short: BUY. EPS growth 12.00%, no dividend, FWD PE 18.7 against a fair exit 17.6, expected return 11.41%, fair value 2,094.3 against 1,780.2 = 15.00% undervalued.

SOD $1,781.10
2026-APR-12 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,954.53

In short: #4, and the coffee-can name reappearing in a new frame. "Markel is often seen as a mini Berkshire Hathaway. It's an insurance company led by Tom Gayner. The interesting thing is that they can reinvest their insurance float in listed stocks as well as fully owned private businesses." Top five equity positions: Berkshire Hathaway 12.8%, Alphabet 6.9%, Brookfield Corporation 4.8%, Amazon 3.7%, Deere 3.3%. Record: 9.9% a year since 2001 — the second-weakest on the captured list, and notably below the market over that stretch, which the post does not comment on.

In plain English

Markel sells specialist insurance. Because customers pay premiums up front and claims are paid later, the company sits on a large pool of other people's money in the meantime — the "float" — and it invests that money rather than leaving it idle.

Tom Gayner runs the investing, and he can put the float into shares of listed companies and into businesses Markel buys outright. Its five largest stock positions are Berkshire Hathaway at 12.8%, Alphabet at 6.9%, Brookfield at 4.8%, Amazon at 3.7% and Deere at 3.3% — which is why it is called a mini Berkshire Hathaway.

The record is the sober part: about 9.9% a year since 2001, below the US market over the same period. The post prints the number and does not discuss it.

SOD $1,954.53 (open 2026-APR-10)
2026-MAR-19 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,914.15

In short: BUY on the weakest arithmetic of any name here. Fair value $1,652.2 against a $1,966.7 price (20.0% over), 18.7x forward against an 18.7x five-year average (6.2% over), and an expected return of 7.4% — the joint-lowest on the sheet. Only the +2.3pp reverse-DCF margin supports it.

SOD $1,914.15
2026-FEB-05 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$2,100.00

In short: BUY on the thinnest margin on the sheet. A $2,062.2 fair value against a $2,059.51 price — 0.1% under — and trading 7.4% above its own five-year multiple (18.9x against 17.6x). Only a 10.0% expected return and a +4.5pp reverse-DCF margin keep it on the list. The "mini-Berkshire" of the coffee-can list, here priced at fair value.

SOD $2,100.00
2026-JAN-20 · Pieter Slegers · Compounding Quality (Substack, free #QualityTuesday post) · Positiveinsight · read ↗ · source page ↗$2,050.00

In short: The week's stock pitch. The model is stated as a two-engine machine: "Markel makes money by selling specialty insurance. It collects premiums first and, over time, pays out less in claims than it takes in to generate a profit. The premiums it holds before paying claims ('float') are then invested in stocks, bonds, and private businesses to make more money." On the underwriting side, "it specializes in niche insurance markets [where] the company prices risks better than competitors." On the capital side, "Markel doesn't stop at insurance. It reinvests its float into a high-quality investment portfolio and wholly owned businesses." Verdict: "often called a mini-Berkshire Hathaway… This combination of insurance and investing is what makes Markel very powerful. It's built to compound over the long run." No multiple, fair value or expected return is given — consistent with the format.

In plain English

Markel sells insurance for unusual risks — the policies a standard insurer will not write — and it makes money in two separate ways from the same premium.

The first is ordinary: charge more in premiums than it eventually pays out in claims. Markel's claim is that it can do this because it works in narrow niches where it understands the risk better than the competition prices it.

The second is the part that makes it interesting. Insurance premiums arrive years before the claims are paid, so at any moment the company is sitting on a large pile of other people's money — the industry calls it the float. Markel invests that pile in shares, bonds and whole private businesses it buys outright. So it earns an investment return on capital it did not have to raise and does not have to pay interest on.

That is precisely the machine Warren Buffett built at Berkshire Hathaway, which is why Markel is routinely described as a mini-Berkshire — and why it appears in an issue framed around Buffett's retirement. The obvious caution is that this pitch, like every one in the free Tuesday format, contains no price: it tells you the business is good, and says nothing about whether the shares are worth buying today.

SOD $2,050.00
2025-APR-20 · Pieter Slegers · Thoughtful Money (host Adam Taggart) · Neutralmention · ▶ 34:36 · source page ↗$1,763.25

In short: Named in passing as an "old-schooled" insurer comp — the kind of carrier that runs 10–15 separate platforms for different risks, contrasted against Kinsale's single-platform tech advantage. Not a stance on Markel itself.

34:36And on top of that, a lot of traditional insurance companies, they are very old schooled. So meaning if you take Markel or other companies, often they use 10, 15 different platforms and different technological tools for different risks in their business. Well, Kinsale Capital in some way can also be seen as a technology company, meaning they have everything in one platform.

SOD $1,763.25 (open 2025-APR-17)
2024-FEB-22 · Pieter Slegers · Compounding Quality (Substack) · Positiveinsight · read ↗ · source page ↗$1,467.32

In short: #4. "Markel can be seen as a 'mini-Berkshire Hathaway'" — insurance, reinsurance and investments in one holding. "The company invests its float, which leverages their growth. Markel has an excellent company culture."

In plain English

Markel writes specialty insurance and reinsurance, and then invests the premiums it holds before claims come due. That held-back money is called float, and it works like a long-term, low-cost loan the company gets to invest for its own account — so profits come both from underwriting well and from investing the float well.

Slegers describes it as a "mini-Berkshire Hathaway": the same structure of insurance plus investments plus wholly-owned operating businesses, at a size that still has room to grow. He rates the culture explicitly, which for a 50-year hold matters more than this year's combined ratio.

SOD $1,467.32

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.